Delivery Order SPE2DB20D1100-SPE2DB22FC7P6
Award Date 7/28/22
Potential Completion Date 8/18/22
Potential Value $131K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 300 mg/10 mL vials of the pharmaceutical OCREVUS. The $131,171.40 award has an August 24, 2022 completion date and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a prime contractor that has received numerous prior DLA contract awards to provide pharmaceuticals, medical supplies, and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 300 mg/10 ml vials of the pharmaceutical OCREVUS. The $69,354.24 award is for delivery by February 1, 2024. Amerisourcebergen Drug Corp, which operates out of its corporate office in Conshohocken, Pennsylvania, has an extensive history of supplying pharmaceuticals and medical supplies to DLA, including under an indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 300 mg/10 mL vials of the pharmaceutical product OCREVUS. The $163,964.25 award has a completion date of March 10, 2022 and was made on February 16, 2022. Amerisourcebergen Drug Corp is a prime contractor that has received multiple DLA awards to provide pharmaceuticals, medical supplies, and related distribution services in...
- The Defense Logistics Agency (DLA) awarded a $92,472.32 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ocrevus 300 mg/10 ml vials in support of DLA Troop Support Medical. This delivery order contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is a prime contractor that has previously received numerous awards from DLA to supply pharmaceuticals, medical supplies, and distribution...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 300 mg/10 ml vials of the pharmaceutical product OCREVUS. The $112,653.60 delivery order has a completion date of May 25, 2023 and was awarded on May 4, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceuticals, medical supplies, and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product OCREVUS 300 MG/10 ML VIAL 10ML. The order has a potential value of $23,118.08 and a completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) the company...
- The Defense Logistics Agency (DLA) awarded a $75,998.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials. The contract was competitively awarded without set-aside provisions and is scheduled for completion by November 19, 2025. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide OCREVUS 300 MG/10 ML VIAL 10ML. The $23,118.08 contract has a June 3, 2024 ultimate completion date. This award is made under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $131,171.40 order is for 300 mg/10 mL vials of the pharmaceutical product OCREVUS, to be delivered by September 6, 2022. There was no set-aside designation used for this award. AmerisourceBergen Drug Corp is a prime contractor that provides a range of pharmaceutical and medical supply products and services to support U.S....
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,042,504 units of the pharmaceutical product OCREVUS 300 MG/10 ML VIAL 10ML. The contract has a ceiling value of $115,590.40 and a period of performance through April 11, 2024. AmerisourceBergen Drug Corp is the prime contractor and the parent company Cencora, Inc. is the parent vendor. This...